CT2 Program Lecture Series

All lectures are on Tuesdays from 12 to 1 p.m. in Comer Commons at Moores Cancer Center (directions and map). Lunch is available at 11:45 a.m. for those attending the lecture. 

Principles of Cancer Drug Therapeutics Development

This is a required series of 12 weekly lectures delivered by CT2 and UC San Diego faculty members during fall quarter. They focus on the necessary sequential steps in drug development.

Topics in Cancer Drug Development

This is a series of 10 monthly lectures by industry leaders in cancer drug development. The goal is to expose trainees to experts with a substantial track record in the “real life” challenges of cancer drug development. The lecturers are typically CEOs, directors of research, or medical directors from companies in the San Diego biomedical community, although experts from large pharmaceutical companies have also participated. The outside speakers are invited to discuss challenges of developing a given target or novel therapeutic and give fellows an opportunity to hear the story of the development of specific therapeutic agents.

2016-2017 Lecture Series

Upcoming Lectures

1/10/17Januario Castro, MD

Moores UCSD 
Cancer Center

RNA Splicing in  Cancer
1/17/17Ezra Cohen, MD

Moores UCSD 
Cancer Center

Immune Approaches in Head and Neck Cancer
1/24/17Brett MoniaIonis PharmaceuticalsAntisense Strategies for Cancer Drug Development
1/31/17Eric Ahrens

Moores UCSD 
Cancer Center

Title TBD
2/7/17Michael RothenbergLoxo PharmaceuticalsTargeting Addicting Kinases in Cancer—a Drug Development Perspective
2/14/17Hatim Hussain, MD

Moores UCSD 
Cancer Center

Title TBD
2/21/17William Go, MDKite PharmaceucticalsAnti-CD19 CAR T for B cell lymphoma
​2/28/17No lecture
​3/7/17Michael Reich, PhDMoores UCSD
Cancer Center
​Tools and Methods for Genomic Computation, Visualization, and Integration
​3/14/17Kathryn Gold, MDMoores UCSD 
Cancer Center
Development of Ibrutinib for Solid Tumors
​3/28/17Adriana ComprelliBristol-Myers SquibbTBD
​4/4/17​No lecture
​4/11/17Karl Willert, PhD​California Institute for Regenerative MedicineTBD

Schedules for previous years